alnylam
The Associate Director, Biostatistics leads statistical activities for clinical trials, including contributing to trial designs, authoring protocol sections, and preparing statistical analysis plans. This role involves collaborating with cross-functional teams to drive clinical development, providing statistical guidance, and representing the company in regulatory and stakeholder meetings. The position requires managing CRO support and contributing to scientific and regulatory documentation.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
Associate Director, Biostatistics
Alnylam Pharmaceuticals
Senior Director, Biostatistics
Rhythm Pharmaceuticals
Associate Director, Biostatistics
Rhythm Pharmaceuticals
Associate Director, Biostatistics
Replimune
【Alexion Japan】Senior Manager, Biostatistics
AstraZeneca
Associate Director, Biostatistics
Relay Therapeutics